269 related articles for article (PubMed ID: 36264305)
1. Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease.
Nee R; Yuan CM; Narva AS; Yan G; Norris KC
Nephrol Dial Transplant; 2023 Feb; 38(3):532-541. PubMed ID: 36264305
[TBL] [Abstract][Full Text] [Related]
2. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
de Boer IH; Khunti K; Sadusky T; Tuttle KR; Neumiller JJ; Rhee CM; Rosas SE; Rossing P; Bakris G
Kidney Int; 2022 Nov; 102(5):974-989. PubMed ID: 36202661
[TBL] [Abstract][Full Text] [Related]
3. Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney Disease.
Neumiller JJ; Alicic RZ; Tuttle KR
Semin Nephrol; 2023 May; 43(3):151427. PubMed ID: 37857231
[TBL] [Abstract][Full Text] [Related]
4. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment.
de Boer IH; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Khunti K; Liew A; Michos ED; Navaneethan SD; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Zoungas S; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Rossing P
Kidney Int; 2020 Oct; 98(4):839-848. PubMed ID: 32653403
[TBL] [Abstract][Full Text] [Related]
5. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.
Mottl AK; Alicic R; Argyropoulos C; Brosius FC; Mauer M; Molitch M; Nelson RG; Perreault L; Nicholas SB
Am J Kidney Dis; 2022 Apr; 79(4):457-479. PubMed ID: 35144840
[TBL] [Abstract][Full Text] [Related]
6. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
Navaneethan SD; Zoungas S; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Liew A; Michos ED; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Craig JC; Tunnicliffe DJ; Tonelli M; Cheung M; Earley A; Rossing P; de Boer IH; Khunti K
Ann Intern Med; 2023 Mar; 176(3):381-387. PubMed ID: 36623286
[TBL] [Abstract][Full Text] [Related]
7. Sodium-Glucose Cotransporter-2 Inhibitors-Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials.
Gohda T; Murakoshi M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430228
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
Sridhar VS; Limonte CP; Groop PH; Heerspink HJL; Pratley RE; Rossing P; Skyler JS; Cherney DZI
Diabetologia; 2024 Jan; 67(1):3-18. PubMed ID: 37801140
[TBL] [Abstract][Full Text] [Related]
9. Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations.
Shubrook JH; Neumiller JJ; Wright E
Postgrad Med; 2022 May; 134(4):376-387. PubMed ID: 34817311
[TBL] [Abstract][Full Text] [Related]
10. Advances in the management of chronic kidney disease.
Chen TK; Hoenig MP; Nitsch D; Grams ME
BMJ; 2023 Dec; 383():e074216. PubMed ID: 38052474
[TBL] [Abstract][Full Text] [Related]
11. Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease.
Tuttle KR; Wong L; St Peter W; Roberts G; Rangaswami J; Mottl A; Kliger AS; Harris RC; Gee PO; Fowler K; Cherney D; Brosius FC; Argyropoulos C; Quaggin SE;
Clin J Am Soc Nephrol; 2022 Jul; 17(7):1092-1103. PubMed ID: 35649722
[TBL] [Abstract][Full Text] [Related]
12. Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States.
Wright EE; Nicholas SB
Postgrad Med; 2024 May; 136(4):347-357. PubMed ID: 38712604
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week.
Morales J; Handelsman Y
J Am Coll Cardiol; 2023 Jul; 82(2):161-170. PubMed ID: 37407115
[TBL] [Abstract][Full Text] [Related]
14. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD.
Mottl AK; Nicholas SB
Am J Kidney Dis; 2024 Mar; 83(3):277-287. PubMed ID: 38142396
[TBL] [Abstract][Full Text] [Related]
15. Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease.
Limonte CP; Lamprea-Montealegre JA; Tuttle KR
Semin Nephrol; 2024 May; ():151520. PubMed ID: 38705774
[TBL] [Abstract][Full Text] [Related]
16. Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
Yang S; Zhao L; Mi Y; He W
Diabetes Obes Metab; 2022 Nov; 24(11):2159-2168. PubMed ID: 35712807
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary proactive e-consults to improve guideline-directed medical therapies for patients with diabetes and chronic kidney disease: an implementation study.
Rikin S; Bauman L; Arnaoudova I; DiPalo K; Suda N; Gupta S; Deng Y; Golestaneh L
BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719510
[TBL] [Abstract][Full Text] [Related]
18. Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade.
Shenoy SV; Nagaraju SP; Bhojaraja MV; Prabhu RA; Rangaswamy D; Rao IR
Nephrology (Carlton); 2021 Nov; 26(11):858-871. PubMed ID: 34176194
[TBL] [Abstract][Full Text] [Related]
19. Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus.
Wish JB; Pergola P
Mayo Clin Proc Innov Qual Outcomes; 2022 Dec; 6(6):536-551. PubMed ID: 36277502
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study.
Chu L; Fuller M; Jervis K; Ciaccia A; Abitbol A
Clin Ther; 2021 Sep; 43(9):1558-1573. PubMed ID: 34426012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
